The TOLL of inflammation in multiple myeloma

被引：1
|
作者：
Bell, Jessica K. [1 ]
机构：
[1] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA
来源：
CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 01期
关键词：
multiple myeloma; inflammation; toll-like receptor 4; lipopolysaccharide; interleukin-18; STRUCTURAL BASIS; IFN-BETA; RECEPTORS; CELLS; RECOGNITION; EXPRESSION; PROLIFERATION; SURVIVAL; PATHWAY; CANCER;
D O I：
10.4161/cbt.11.1.14153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 70
页数：3
相关论文
共 50 条
  • [31] Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma
    Allegra, Alessandro
    Cicero, Nicola
    Tonacci, Alessandro
    Musolino, Caterina
    Gangemi, Sebastiano
    CANCERS, 2022, 14 (07)
  • [32] Transcriptomic rationale for the synergy observed with dasatinib plus bortezomib plus dexamethasone in multiple myeloma
    de Queiroz Crusoe, Edvan
    Maiso, Patricia
    Fernandez-Lazaro, Diego
    San-Segundo, Laura
    Garayoa, Mercedes
    Garcia-Gomez, Antonio
    Gutierrez, Norma C.
    Delgado, Manuel
    Colado, Enrique
    Martin-Sanchez, Jesus
    Lee, Francis Y.
    Ocio, Enrique M.
    ANNALS OF HEMATOLOGY, 2012, 91 (02) : 257 - 269
  • [33] Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma
    Jia, Yachun
    Liu, Rui
    Shi, Luyi
    Feng, Yuandong
    Zhang, Linlin
    Guo, Ni
    He, Aili
    Kong, Guangyao
    BMC CANCER, 2023, 23 (01)
  • [34] Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma
    Tsirakis, G.
    Pappa, C. A.
    Psarakis, F. E.
    Fragioudaki, M.
    Tsioutis, C.
    Stavroulaki, E.
    Boula, A.
    Alexandrakis, M. G.
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2396 - 2401
  • [35] Pomalidomide for multiple myeloma
    Fouquet, Guillemette
    Bories, Claire
    Guidez, Stephanie
    Renaud, Loic
    Herbaux, Charles
    Javed, Sahir
    Facon, Thierry
    Leleu, Xavier
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (06) : 719 - 731
  • [36] Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-κB
    Xu, Yang
    Zhao, Yun
    Huang, Haiwen
    Chen, Guanghua
    Wu, Xiaojin
    Wang, Ying
    Chang, Weirong
    Zhu, Ziling
    Feng, Yufeng
    Wu, Depei
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (05) : 543 - 553
  • [37] A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo
    Tang, Juan
    Zhu, Jingyu
    Yu, Yang
    Zhang, Zubin
    Chen, Guodong
    Zhou, Xiumin
    Qiao, Chunhua
    Hou, Tingjun
    Mao, Xinliang
    ONCOTARGET, 2014, 5 (11) : 3836 - 3848
  • [38] Hepcidin and GDF15 in anemia of multiple myeloma
    Mei, Shuchong
    Wang, Huaquan
    Fu, Rong
    Qu, Wen
    Xing, Limin
    Wang, Guojin
    Song, Jia
    Liu, Hong
    Li, Juan
    Wang, Xiaoming
    Wu, Yuhong
    Guan, Jin
    Ruan, Erbao
    Shao, Zonghong
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (03) : 266 - 273
  • [39] Toll-like receptors: Expression and involvement in Multiple Myeloma
    Chiron, David
    Jego, Gaetan
    Pellat-Deceunynck, Catherine
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1545 - 1550
  • [40] Clinical significance of interleukin-22 in multiple myeloma
    Tsirakis, George
    Pappa, Constantina A.
    Kolovou, Anna
    Kokonozaki, Maria
    Neonakis, Ioannis
    Alexandrakis, Michael G.
    HEMATOLOGY, 2015, 20 (03) : 143 - 147
12345